Sarepta Therapeutics (SRPT) PT Lowered to $35 at Oppenheimer

August 6, 2026 8:37 AM EDT
Get Alerts SRPT Hot Sheet
Price: $22.50 -2.13%

Rating Summary:
    19 Buy, 18 Hold, 6 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $37.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change